医学
危险系数
肾病
前瞻性队列研究
内科学
比例危险模型
糖尿病
队列研究
糖尿病肾病
入射(几何)
2型糖尿病
1型糖尿病
糖尿病神经病变
队列
风险因素
蛋白尿
周围神经病变
胃肠病学
流行病学
病例对照研究
外科
蛋白尿
合并分析
免疫病理学
免疫学
相对风险
作者
Cecilia Martinez Escobedo1,Anna Birukov,Ralph Heijmans,Olga Kuxhaus,Fabian Eichelmann,Roderick C. Slieker,Elham Memarian,Nina Šimunić-Briški,Femke Rutters,Marieke T. Blom,Marta Riera,Marta Crespo,Manfred Wuhrer,Clara Barrios,Mandy van Hoek,Leen M. ‘t Hart,Eric J.G. Sijbrands,Gordan Lauc,Matthias Bernd Schulze,Clemens Wittenbecher
出处
期刊:Diabetes Care
[American Diabetes Association]
日期:2026-07-17
卷期号:49 (9): 1714-1719
被引量:1
摘要
OBJECTIVE: To examine whether IgG N-glycosylation patterns are prospectively associated with incident diabetic nephropathy and neuropathy. RESEARCH DESIGN AND METHODS: We analyzed IgG N-glycosylation profiles in four cohorts: EPIC-Potsdam, DiaGene, GenoDiabMar, and Hoorn DCS. Among 3,263 individuals with and without type 2 diabetes at profiling, 674 incident neuropathy and 639 incident nephropathy cases occurred after diabetes diagnosis. Associations of IgG N-glycan peaks (IgG-GPs) and traits with incident outcomes were examined using Cox models and meta-analyzed across cohorts. RESULTS: Agalactosylated, asialylated, and bisected IgG-GPs were associated with higher nephropathy risk (IgG-GP3: hazard ratio [HR] 1.13 [95% CI 1.04-1.24]; IgG-GP4: HR 1.15 [95% CI 1.05-1.26]), while galactosylated and sialylated IgG-GPs were associated with lower risk (IgG-GP14: HR 0.86 [95% CI 0.78-0.94]; IgG-GP18: HR 0.85 [95% CI 0.77-0.94]) (all false discovery rate <0.05). Associations of IgG-GPs with incident neuropathy were rendered nonsignificant after multiple testing correction. CONCLUSIONS: IgG N-glycosylation may reflect immune-related mechanisms relevant to diabetic nephropathy; but the evidence between IgG-GPs and diabetic neuropathy remains inconclusive.
科研通智能强力驱动
Strongly Powered by AbleSci AI